According to Inside INdiana Business, Indianapolis-based Eli Lilly and Co. has reached a licensing and collaboration agreement with Transition Therapeutics Inc. The Canadian company specializes in an emerging class of potential disease-modifying therapies for diabetes patients. The agreement gives Lilly exclusive worldwide rights to develop and commercialize the therapies.
Friday, March 14, 2008
Another Canadian Link for Indy
According to Inside INdiana Business, Indianapolis-based Eli Lilly and Co. has reached a licensing and collaboration agreement with Transition Therapeutics Inc. The Canadian company specializes in an emerging class of potential disease-modifying therapies for diabetes patients. The agreement gives Lilly exclusive worldwide rights to develop and commercialize the therapies.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment